Synonyms: ZE63-0302
Comment: The chemical structure for balomenib was derived from WHO proposed INN list 132 (Feb 2025), in which it is listed as a menin inhibitor with antineoplastic potential. An internet search aligns the INN with the clinical candidate ZE63-0302 (Eilean Therapeutics). ZE63-0302 is described as an oral inhibitor of the menin-KMT2A interaction, which is a validated anti-tumour mechanism. ZE63-0302 is designed to retain activity against menin inhibitor resistance mutations, and it also has more a favourable safety profile with regard to QTc prolongation and cardiotoxicity than preceeding menin inhibitors.
|
|
2D Structure
|
|
Physico-chemical Properties
|
|
Hydrogen bond acceptors
|
9
|
Hydrogen bond donors
|
1
|
Rotatable bonds
|
7
|
Topological polar surface area
|
96.56
|
Molecular weight
|
617.67
|
XLogP
|
2.35
|
No. Lipinski's rules broken
|
1
|
Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
|
SMILES / InChI / InChIKey
|
|
Canonical SMILES
|
CC1=C(C=CC2=C1C=C(C#N)N2C[C@@H]3CNC(=O)CO3)CN4CCC5(CC4)CN(C5)C6=NC=NC7=CC=C(C=C76)CC(F)(F)F
|
Isomeric SMILES
|
CC1=C2C=C(N(C2=CC=C1CN3CCC4(CN(C4)C5=NC=NC6=CC=C(C=C56)CC(F)(F)F)CC3)C[C@@H]7CNC(CO7)=O)C#N
|
InChI
|
InChI=1S/C33H34F3N7O2/c1-21-23(3-5-29-26(21)11-24(13-37)43(29)16-25-14-38-30(44)17-45-25)15-41-8-6-32(7-9-41)18-42(19-32)31-27-10-22(12-33(34,35)36)2-4-28(27)39-20-40-31/h2-5,10-11,20,25H,6-9,12,14-19H2,1H3,(H,38,44)/t25-/m0/s1
|
InChI Key
|
GTFGTNVSMRVPEN-VWLOTQADSA-N
|
Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
|
|